Analysis of biomolecular interaction without real -time labels with unprecedented sensitivity and performance

The Life Sartorius Scientific Group is launching a new Okett^® The Biological Interferometry System R8E (BLI), providing researchers with the most advanced possibilities of detecting existing analyzes in real time, high -pass analysis of protein protein, small protein particles and other biomolecular interactions. Expanding the Oketta leading in the industry without liquidity^® The Blog, R8E portfolio is intended for applications that require higher sensitivity, a flexible test project and longer running times.

Using the restricted BLA Sartorius technology for fast, in real time and without kinetic labels of binding characteristics, ocet^® The R8E provides the sensitivity of the next level for accurate generation of data with the lowest detection limits, expanding the range of analytions to low molecular weight (> 100 DA) and low appointment (> 10 PM) of analytals. Compatibility with 96- and 384-3-degree plates offers additional flexibility in test design, enabling adaptation to a unique scale, complexity and costs of each test.

Octet^® R8E is our most advanced BLY system, designed for future research by increasing the role in discovering and development. Provides performance and reliability of today’s scientists to deal with new goals, emerging methods and more and more complex programs “,”

Nilshad Salim, OCTET product manager^® Systems, Sartorius

The integrity of the sample is a frequent challenge in BIRT tests when long -term kinetic measurements are required to observe slow binding or dissociation interactions. New Evaporation cover created for the octto^® The R8E system minimizes the evaporation of the sample from 96-speed micropłas, maintaining the sample concentration for up to 16 hours. This ensures accuracy in relation to long -term times, enabling greater possibilities of collecting data without manual intervention.

Adds Salim.

Octet^® Bark systems have a large global installation base in regulated environments in pharmaceutical, biotechnology and CRO organizations, with successful use of new drugs in many studies. Strengthening high -quality scientists, flexibility and user -friendly project^® The R8E system has been designed to accelerate biofarmaceutical tests at every stage – from discovering drugs to development, bioprocessing and quality control – while the laboratory equipped with future applications.